Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma

Hideya Takeuchi, Yoshihiko Maehara, Eriko Tokunaga, Takashi Koga, Yoshihiko Kakeji, Keizo Sugimachi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Aims: Immunosuppressive acidic protein has been found to suppress both phytohemagglutinin-induced lymphocyte blast formation and mixed lymphocyte reaction in vitro. The level of immunosuppressive acidic protein has revealed clear increases with the progression of cancer, and has been reported to be a useful diagnostic and follow-up marker for ovarian and renal cancer. We examined immunosuppressive acidic protein levels in patients with gastric cancer to examine the influence of clinical parameters. Methodology: The present study was based on a retrospective analyses of data on 107 patients with gastric cancer, all of whom had been surgically treated in the Department of Surgery II, Kyushu University Hospital from 1988 to 1992. All patients were examined for immunosuppressive acidic protein level, based on a peripheral blood sampling done preoperatively. Results: Significant associations among immunosuppressive acidic protein level and clinicopathological parameters, including lymphatic involvement, vascular involvement, and lymph node metastases were evident. The 5-year survival rates were 75.9% and 92.1% for those with immunosuppressive acidic protein level ≥355 and <355, respectively, the value being statistically significant (P<0.05). Conclusions: These data show that immunosuppressive acidic protein levels may be related to lymph node metastases. Measurement of preoperative immunosuppressive acidic protein levels may be pertinent for the prognosis of patients with gastric cancer and for follow-up clinical management.

Original languageEnglish
Pages (from-to)289-292
Number of pages4
JournalHepato-Gastroenterology
Volume50
Issue number49
Publication statusPublished - Jan 1 2003

Fingerprint

Stomach
Carcinoma
Stomach Neoplasms
Lymph Nodes
Neoplasm Metastasis
Mixed Lymphocyte Culture Test
immunosuppressive acidic protein
Kidney Neoplasms
Phytohemagglutinins
Ovarian Neoplasms
Blood Vessels
Survival Rate
Lymphocytes
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cite this

Takeuchi, H., Maehara, Y., Tokunaga, E., Koga, T., Kakeji, Y., & Sugimachi, K. (2003). Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma. Hepato-Gastroenterology, 50(49), 289-292.

Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma. / Takeuchi, Hideya; Maehara, Yoshihiko; Tokunaga, Eriko; Koga, Takashi; Kakeji, Yoshihiko; Sugimachi, Keizo.

In: Hepato-Gastroenterology, Vol. 50, No. 49, 01.01.2003, p. 289-292.

Research output: Contribution to journalArticle

Takeuchi, H, Maehara, Y, Tokunaga, E, Koga, T, Kakeji, Y & Sugimachi, K 2003, 'Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma', Hepato-Gastroenterology, vol. 50, no. 49, pp. 289-292.
Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K. Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma. Hepato-Gastroenterology. 2003 Jan 1;50(49):289-292.
Takeuchi, Hideya ; Maehara, Yoshihiko ; Tokunaga, Eriko ; Koga, Takashi ; Kakeji, Yoshihiko ; Sugimachi, Keizo. / Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma. In: Hepato-Gastroenterology. 2003 ; Vol. 50, No. 49. pp. 289-292.
@article{071303c254d54019bf40c2cad9b95a1d,
title = "Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma",
abstract = "Background/Aims: Immunosuppressive acidic protein has been found to suppress both phytohemagglutinin-induced lymphocyte blast formation and mixed lymphocyte reaction in vitro. The level of immunosuppressive acidic protein has revealed clear increases with the progression of cancer, and has been reported to be a useful diagnostic and follow-up marker for ovarian and renal cancer. We examined immunosuppressive acidic protein levels in patients with gastric cancer to examine the influence of clinical parameters. Methodology: The present study was based on a retrospective analyses of data on 107 patients with gastric cancer, all of whom had been surgically treated in the Department of Surgery II, Kyushu University Hospital from 1988 to 1992. All patients were examined for immunosuppressive acidic protein level, based on a peripheral blood sampling done preoperatively. Results: Significant associations among immunosuppressive acidic protein level and clinicopathological parameters, including lymphatic involvement, vascular involvement, and lymph node metastases were evident. The 5-year survival rates were 75.9{\%} and 92.1{\%} for those with immunosuppressive acidic protein level ≥355 and <355, respectively, the value being statistically significant (P<0.05). Conclusions: These data show that immunosuppressive acidic protein levels may be related to lymph node metastases. Measurement of preoperative immunosuppressive acidic protein levels may be pertinent for the prognosis of patients with gastric cancer and for follow-up clinical management.",
author = "Hideya Takeuchi and Yoshihiko Maehara and Eriko Tokunaga and Takashi Koga and Yoshihiko Kakeji and Keizo Sugimachi",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "50",
pages = "289--292",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "49",

}

TY - JOUR

T1 - Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma

AU - Takeuchi, Hideya

AU - Maehara, Yoshihiko

AU - Tokunaga, Eriko

AU - Koga, Takashi

AU - Kakeji, Yoshihiko

AU - Sugimachi, Keizo

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Background/Aims: Immunosuppressive acidic protein has been found to suppress both phytohemagglutinin-induced lymphocyte blast formation and mixed lymphocyte reaction in vitro. The level of immunosuppressive acidic protein has revealed clear increases with the progression of cancer, and has been reported to be a useful diagnostic and follow-up marker for ovarian and renal cancer. We examined immunosuppressive acidic protein levels in patients with gastric cancer to examine the influence of clinical parameters. Methodology: The present study was based on a retrospective analyses of data on 107 patients with gastric cancer, all of whom had been surgically treated in the Department of Surgery II, Kyushu University Hospital from 1988 to 1992. All patients were examined for immunosuppressive acidic protein level, based on a peripheral blood sampling done preoperatively. Results: Significant associations among immunosuppressive acidic protein level and clinicopathological parameters, including lymphatic involvement, vascular involvement, and lymph node metastases were evident. The 5-year survival rates were 75.9% and 92.1% for those with immunosuppressive acidic protein level ≥355 and <355, respectively, the value being statistically significant (P<0.05). Conclusions: These data show that immunosuppressive acidic protein levels may be related to lymph node metastases. Measurement of preoperative immunosuppressive acidic protein levels may be pertinent for the prognosis of patients with gastric cancer and for follow-up clinical management.

AB - Background/Aims: Immunosuppressive acidic protein has been found to suppress both phytohemagglutinin-induced lymphocyte blast formation and mixed lymphocyte reaction in vitro. The level of immunosuppressive acidic protein has revealed clear increases with the progression of cancer, and has been reported to be a useful diagnostic and follow-up marker for ovarian and renal cancer. We examined immunosuppressive acidic protein levels in patients with gastric cancer to examine the influence of clinical parameters. Methodology: The present study was based on a retrospective analyses of data on 107 patients with gastric cancer, all of whom had been surgically treated in the Department of Surgery II, Kyushu University Hospital from 1988 to 1992. All patients were examined for immunosuppressive acidic protein level, based on a peripheral blood sampling done preoperatively. Results: Significant associations among immunosuppressive acidic protein level and clinicopathological parameters, including lymphatic involvement, vascular involvement, and lymph node metastases were evident. The 5-year survival rates were 75.9% and 92.1% for those with immunosuppressive acidic protein level ≥355 and <355, respectively, the value being statistically significant (P<0.05). Conclusions: These data show that immunosuppressive acidic protein levels may be related to lymph node metastases. Measurement of preoperative immunosuppressive acidic protein levels may be pertinent for the prognosis of patients with gastric cancer and for follow-up clinical management.

UR - http://www.scopus.com/inward/record.url?scp=0037270069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037270069&partnerID=8YFLogxK

M3 - Article

VL - 50

SP - 289

EP - 292

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 49

ER -